Ionis Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $346.0K | $-60.4M | $-88.3M | $-39.0M | $-60.6M | $-65.5M | $-84.8M | $-61.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $6.7M | $7.5M | $7.0M | $6.4M | $6.6M | $7.1M | $6.6M | $4.8M |
| Amortization | $1.6M | $1.6M | — | — | — | — | — | — |
| Stock-Based Compensation | $86.0M | $72.1M | $59.3M | $31.4M | $11.4M | $8.6M | $9.8M | $12.2M |
| Net Cash from Operating Activities | $174.1M | $-112.1M | $21.1M | $6.3M | $63.5M | $1.9M | $-114.8M | $-63.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $34.8M | $7.1M | $7.7M | $7.5M | $1.6M | $1.5M | $10.2M | $13.2M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-358.3M | $56.6M | $-60.1M | — | — | — | $110.9M | $23.7M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $0 | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $229.1M | $11.4M | $24.7M | — | — | — | $-672.0K | $4.7M |
| Net Change in Cash | $44.9M | $-44.1M | $-14.2M | — | — | — | $-4.6M | $-35.2M |
| Free Cash Flow | $139.4M | $-119.2M | $13.4M | $-1.2M | $61.9M | $397.0K | $-125.0M | $-76.8M |